SUNSHINE BIOPHARMA INC. (SBFMW) Free cash flow 2016–2025
SUNSHINE BIOPHARMA INC. (SBFMW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$5.5MFY2025 · since FY2016: -$317,621 → -$5.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.5M | +61.2% |
| FY2024 | -$14.2M | -60.1% |
| FY2023 | -$8.9M | -62.7% |
| FY2022 | -$5.4M | -197.5% |
| FY2021 | -$1.8M | -177.8% |
| FY2020 | -$658,490 | -32.6% |
| FY2019 | -$496,658 | +6.6% |
| FY2018 | -$531,656 | +2.8% |
| FY2017 | -$547,238 | -72.3% |
| FY2016 | -$317,621 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice